Stock screenerAll disclosures →
EDGAR →
NRC
Conviction 91HealthcareScan · Mon, Aug 10, 2026NRC$20.98+3.12%
ResistanceSupportVol 14Vol MA14 141.45K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price20.98
Change+3.12%
Gap+0.49%
Rel volume4.76×
Avg volume119.53K
Avg $ vol2.44M
SMA 2020.67
SMA 5020.47
SMA 20017.83
Price vs 50+2.45%
Price vs 200+17.64%
MA stackbullish
50/200 cross—
Supertrenddown · 23.02
RSI (14)54
MACD hist-0.05
MACD cross—
Stoch %K / %D53 / 41
ADX (14)18
+DI / −DI20 / 20
RSI divergence—
MACD divergenceBearish
ATR %+5.61%
ADR %5.97%
52w high22.77
52w low11.42
From 52w high-7.88%
Above 52w low+83.67%
New 52w highNo
SqueezeOff
Bollinger width22.24%
%B0.57
Donchian pos53.36%
Donchian high23.68
Donchian low17.88
AVWAP (52w high)19.97
vs AVWAP high+5.05%
AVWAP (52w low)17.63
vs AVWAP low+19.00%
OBV trendUp
Chaikin MF (20)-0.04
Today vs 20d4.76×
Avg vol (14d)141.45K
Avg vol (20d)119.53K
Avg $ vol (20d)2.44M
Market cap463.96M
RS 3m (vs SPY)+2.90%
RS 6m (vs SPY)+13.57%
RS line new highNo
Trend template8/8
Technical rank70.6
1 week+7.56%
1 month-3.12%
3 months+11.87%
6 months+31.59%
1 year+42.78%
YTD+16.33%
P/E15.44
P/B70.84
P/S3.38
P/FCF29.47
EPS50.00
Div yield2.37%
ROE458.80%
ROA22.07%
Debt/Eq13.75
Current0.65
EV/EBITDA20.86
Gross margin—
Net margin21.87%
Rev growth-3.96%
EPS growth30.96%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value550.66M
Revenue35.39M
Net income-3.28M
Gross profit—
Free cash flow15.74M
IndustrySERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
ExchangeNasdaq
Shares out—
Employees357
ListedFri, Oct 10, 1997
Free float11.46M
Float %50.6%
Short interest520.82K
Days to cover6.2d
Short volume31.9%
Squeeze score49 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA+
Conviction91 / 100
Pattern quality—
Tech rank70.6 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance23.34
Support17.61
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in NRC
No recent disclosed trades by Congress in NRC. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in NRC · 5 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Lockhart Stephen H Director · Common Stock · 2026-06-23 | Grant | 7.7K | — | 2026-06-23 | 2026-06-25 |
Berwick Donald M Director · Common Stock · 2026-06-23 | Grant | 7.7K | — | 2026-06-23 | 2026-06-25 |
Wheeler Penny Ann Director · Common Stock · 2026-06-23 | Grant | 7.7K | — | 2026-06-23 | 2026-06-25 |
Bhandari Parul Director · Common Stock · 2026-06-23 | Grant | 7.7K | — | 2026-06-23 | 2026-06-25 |
NUNNELLY JOHN N Director · Common Stock · 2026-06-23 | Grant | 7.7K | — | 2026-06-23 | 2026-06-25 |
SEC filings
EDGAR filings in NRC · 4 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.